IP licensing between competitors
The Australian Competition and Consumer Commission (ACCC) recently highlighted the risks involved when competitors enter into IP licence agreements. Background Celgene, a pharmaceutical company, commenced patent infringement proceedings against two manufacturers of generic drugs. The proceedings were settled on the basis that the generic manufacturers would be licensed to launch their products before the expiry…